Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SOPHIA RAHMAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1306142955
CMS profile
684333
Location
PLANO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,375.72

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,375.72 96

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SOPHIA RAHMAN

NPI 1306142955 · CMS profile ID 684333

Allopathic & Osteopathic Physicians / Internal Medicine

PLANO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306142955?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SOPHIA RAHMAN, NPI 1306142955, CMS profile ID 684333. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306142955?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). SOPHIA RAHMAN, NPI 1306142955, CMS profile ID 684333. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306142955?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
SOPHIA RAHMAN, NPI 1306142955, CMS profile ID 684333, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1306142955?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $1,375.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $13.4712/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685502221 CMS
Advanced Accelerator Applications $21.1912/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 708348151 CMS
Amarin Pharma Inc. $15.9412/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699268125 CMS
GlaxoSmithKline, LLC. $14.6711/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670392082 CMS
Novo Nordisk Inc $7.5711/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 690109619 CMS
AbbVie, Inc. $16.9111/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647841263 CMS
Novo Nordisk Inc $12.5011/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704173129 CMS
Merck Sharp & Dohme Corporation $15.6411/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695870505 CMS
Novo Nordisk Inc $4.6111/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474329 CMS
Novo Nordisk Inc $4.6111/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474333 CMS
AstraZeneca Pharmaceuticals LP $14.1011/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685698017 CMS
Novo Nordisk Inc $2.0711/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474337 CMS
Amarin Pharma Inc. $19.9310/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699245647 CMS
Allergan Inc. $12.3810/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670982377 CMS
Astellas Pharma US Inc $17.3210/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655735589 CMS
Amarin Pharma Inc. $6.0210/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699242535 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $98.0710/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684893871 CMS
Novo Nordisk Inc $58.8610/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 690109545 CMS
Merck Sharp & Dohme Corporation $13.0710/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695779975 CMS
Novo Nordisk Inc $1.8410/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474325 CMS
Allergan Inc. $11.4610/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670982373 CMS
Novo Nordisk Inc $15.1010/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675002747 CMS
Novo Nordisk Inc $16.2410/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675002743 CMS
Amarin Pharma Inc. $4.6110/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699228313 CMS
Novo Nordisk Inc $4.6509/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682764757 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.7409/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700226285 CMS
GlaxoSmithKline, LLC. $20.3509/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670744477 CMS
Novo Nordisk Inc $13.7909/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 690109561 CMS
Novo Nordisk Inc $13.9109/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704173115 CMS
Amarin Pharma Inc. $16.7909/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699217121 CMS
IBSA Pharma Inc. $15.0809/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682234593 CMS
AbbVie, Inc. $20.0809/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647841261 CMS
Amarin Pharma Inc. $6.5009/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699214401 CMS
Novo Nordisk Inc $17.4009/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704173111 CMS
Merck Sharp & Dohme Corporation $15.7409/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695724347 CMS
Novo Nordisk Inc $5.0708/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474307 CMS
Amarin Pharma Inc. $4.3408/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699200415 CMS
Coloplast Corp $21.6208/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 696979491 CMS
Kowa Pharmaceuticals America, Inc. $21.0808/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 630294571 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.5108/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684893867 CMS
GlaxoSmithKline, LLC. $17.7608/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670389415 CMS
Merck Sharp & Dohme Corporation $17.2808/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695689159 CMS
Amarin Pharma Inc. $16.1408/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699194065 CMS
Novo Nordisk Inc $3.3308/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474323 CMS
Astellas Pharma US Inc $19.3408/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655735587 CMS
Novo Nordisk Inc $4.1008/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682474317 CMS
Amarin Pharma Inc. $4.5907/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699190097 CMS
GlaxoSmithKline, LLC. $16.6807/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671109084 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.4707/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684893863 CMS
Merck Sharp & Dohme Corporation $13.2707/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695686479 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,375.72 96
PY2020 $292.22 19
PY2021 $650.64 34
PY2022 $158.24 10
PY2023 $396.99 19
PY2024 $94.56 6
PY2025 $105.64 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $41,990.92 22
PY2023 Principal investigator $811,614.84 35
PY2022 Principal investigator $1,323,851.35 26
PY2021 Principal investigator $630,272.09 34
PY2020 Principal investigator $503,977.28 37
PY2019 Principal investigator $9,368.25 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Vanda Pharmaceuticals Inc. $39,069.99 12/20/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951893995
Principal investigator 1 Vanda Pharmaceuticals Inc. $74,152.00 11/21/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951893671
Principal investigator 1 Vanda Pharmaceuticals Inc. $94,718.00 11/02/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951893463
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $325.00 10/25/2022 Non-covered Recipient Entity
Clinrx Research Llc
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 932269263
Principal investigator 1 Vanda Pharmaceuticals Inc. $87,426.40 10/12/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951893241
Principal investigator 1 Vanda Pharmaceuticals Inc. $5,391.10 10/12/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS No dispute reported 06/30/2026 951893247
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,319.64 10/04/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951893097
Principal investigator 1 Vanda Pharmaceuticals Inc. $464.67 09/02/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892861
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,166.25 09/02/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS No dispute reported 06/30/2026 951892867
Principal investigator 1 Vanda Pharmaceuticals Inc. $31,663.00 08/24/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892768
Principal investigator 1 Vanda Pharmaceuticals Inc. $71,691.50 08/03/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892503
Principal investigator 1 Vanda Pharmaceuticals Inc. $26,027.94 07/27/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892439
Principal investigator 1 Vanda Pharmaceuticals Inc. $115.56 07/07/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892195
Principal investigator 1 Vanda Pharmaceuticals Inc. $85,934.72 07/01/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951892101
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,184.00 06/14/2022 Non-covered Recipient Entity
Clinrx Research Llc
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 932269265
Principal investigator 1 Vanda Pharmaceuticals Inc. $142,516.00 05/18/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951891537
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,452.67 05/11/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951891349
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,166.25 05/11/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS No dispute reported 06/30/2026 951891355
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,000.00 05/05/2022 Non-covered Recipient Entity
Clinrx Research Llc
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 932269261
Principal investigator 1 Vanda Pharmaceuticals Inc. $113,165.25 04/13/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951891103
Principal investigator 1 Vanda Pharmaceuticals Inc. $39,753.97 04/06/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951890921
Principal investigator 1 Vanda Pharmaceuticals Inc. $336.44 03/28/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951890755
Principal investigator 1 Vanda Pharmaceuticals Inc. $334,522.75 03/16/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951890633
Principal investigator 1 Vanda Pharmaceuticals Inc. $149,080.25 03/09/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951890455
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $3,328.00 01/10/2022 Non-covered Recipient Entity
Clinrx Research Llc
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 932269267
Principal investigator 1 Vanda Pharmaceuticals Inc. $11,880.00 01/05/2022 Non-covered Recipient Entity
CLINRX RESEARCH LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS No dispute reported 06/30/2026 951889179